Med-X Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Med-X Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
Med-X, Inc. Secures $100 Million Expansion Capital Commitment from Global Emerging Markets (GEM)
MED-X) announced a $100 million capital commitment from GEM Global Yield, LLC SCS (GGY), a Luxembourg-based private alternative investment […]
Disrupt Article
Unlocking Nature to Battle Mosquito Driven Diseases Is Becoming a Reality Post COVID-19 – Disrupt […]
Nature-Cide: Why It Is The Future Of Eco-Friendly Pest Control
Nature-Cide: Why it is the future of eco-friendly pest control.
Med-X Is Well-Positioned To Build An All Natural Pest Control Empire Via A Unique Roll-Up Strategy
Med-X reported over $800,000 dollars in revenue for 2019 and surpassed $1 million for 2020. […]
Two Year Study Finds Nature-Cide as the Top Performing Pesticide for Mosquito Control
Two Year Study Finds Nature-Cide as the Top Performing Pesticide for Mosquito Control
Med-X, Inc.’s Thermal-Aid Products Win Three 2018 National Parenting Publications Awards Joining an Exclusive List of Standout Products for the Whole Family
Med-X, Inc.’s Thermal-Aid Products Win Three 2018 National Parenting Publications Awards Joining an Exclusive List […]
© 2026 Med-X. All rights reserved.